Evidence map›Paper›PMID 35467443›Full record

ArticleJournal of women's health (2002)2022

Computable Guidelines and Clinical Decision Support for Cervical Cancer Screening and Management to Improve Outcomes and Health Equity.

Mona Saraiya, Jean Colbert, Geeta L Bhat, Rose Almonte, David W Winters, Sharon Sebastian, Michael O'Hanlon, Ginny Meadows, Michael R Nosal, Thomas B Richards and 8 more

Open access · greenAbstract read
In one paragraph

Article in Journal of women's health (2002), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Knowledge, Perceptions, and Barriers to Collection of Family Health History Data.Journal of the American Board of Family Medicine : JABFM · 2026
    Article
  6. Process Mapping to Compare and Improve Management of Abnormal Cervical Cancer Screening Results in Two US Healthcare Systems within the PROSPR Consortium.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Commentary: Modernizing Guidelines Development to Speed the Transfer of Science to Patient Care.American journal of medical quality : the official journal of the American College of Medical Quality
    Article
  15. Individual and Geographical Factors Associated With Follow-Up Care After an Abnormal Cervical Cancer Screening Result.Women's health issues : official publication of the Jacobs Institute of Women's Health
    Article
  16. Adapted Kaizen: Multi-Organizational Complex Process Redesign for Adapting Clinical Guidelines for the Digital Age.American journal of medical quality : the official journal of the American College of Medical Quality
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 1 country.

Mona SaraiyaDivision of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Jean ColbertMITRE Healthcare Federally Funded Research and Development Center, McLean, Virginia, USA.
Geeta L BhatMITRE Healthcare Federally Funded Research and Development Center, McLean, Virginia, USA.
Rose AlmonteMITRE Healthcare Federally Funded Research and Development Center, McLean, Virginia, USA.
David W WintersMITRE Healthcare Federally Funded Research and Development Center, McLean, Virginia, USA.
Sharon SebastianMITRE Healthcare Federally Funded Research and Development Center, McLean, Virginia, USA.
Michael O'HanlonMITRE Healthcare Federally Funded Research and Development Center, McLean, Virginia, USA.
Ginny MeadowsMITRE Healthcare Federally Funded Research and Development Center, McLean, Virginia, USA.
Michael R NosalMITRE Healthcare Federally Funded Research and Development Center, McLean, Virginia, USA.
Thomas B RichardsDivision of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Maria MichaelsCenter for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Julie S TownsendDivision of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Jacqueline W MillerDivision of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Rebecca B PerkinsBoston University School of Medicine/Boston Medical Center, Boston, Massachusetts, USA.
George F SawayaUCSF Department of Obstetrics, Gynecology and Reproductive Sciences, San Francisco, California, USA.
Nicolas WentzensenDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Mary C WhiteDivision of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Lisa C RichardsonDivision of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Mitre (United States) · USCenters for Disease Control and Prevention · USBoston University · USNational Cancer Institute · USReproductive Science Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cervical cancer is highly preventable when precancerous lesions are detected early and appropriately managed. However, the complexity of and frequent updates to existing evidence-based clinical guidelines make it challenging for clinicians to stay abreast of the latest recommendations. In addition, limited availability and accessibility to information technology (IT) decision supports make it difficult for groups who are medically underserved to receive screening or receive the appropriate follow-up care. The Centers for Disease Control and Prevention (CDC), Division of Cancer Prevention and Control (DCPC), is leading a multiyear initiative to develop computer-interpretable ("computable") version of already existing evidence-based guidelines to support clinician awareness and adoption of the most up-to-date cervical cancer screening and management guidelines. DCPC is collaborating with the MITRE Corporation, leading scientists from the National Cancer Institute, and other CDC subject matter experts to translate existing narrative guidelines into computable format and develop clinical decision support tools for integration into health IT systems such as electronic health records with the ultimate goal of improving patient outcomes and decreasing disparities in cervical cancer outcomes among populations that are medically underserved. This initiative meets the challenges and opportunities highlighted by the President's Cancer Panel and the President's Cancer Moonshot 2.0 to nearly eliminate cervical cancer.

Indexed as

Decision Support Systems, ClinicalHealth EquityUterine Cervical NeoplasmsEarly Detection of CancerFemaleHumansMass Screeningcancer screeninghealth information technologymedical informaticspractice guidelinesuterine cervical cancer

Identifiers

PMID35467443
PMCPMC9206487
OpenAlexW4224439913

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.